ctrl K

Watchlist Price Alert

Kindred Biosciences Inc. (KIN)

NASDAQ: KIN · Real-Time Price · USD

9.25

0.01 (0.11%)

At close: Apr 24, 2025, 3:47 PM

Kindred Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	11.62M	15.99M	56.3M	34.81M	6.69M
Short-Term Investments	46.76M	55.72M	17.63M	46.21M	50.07M
Long-Term Investments	1.5M	1.84M	n/a	1.5M	1.05M
Other Long-Term Assets	58K	64K	70K	49K	46K
Receivables	624K	923K	903K	n/a	n/a
Inventory	207K	4.22M	3.57M	n/a	n/a
Other Current Assets	3.42M	2.5M	1.66M	797K	1.28M
Total Current Assets	62.62M	79.34M	80.07M	81.82M	58.04M
Property-Plant & Equipment	31.63M	32.78M	26.34M	7.46M	2.44M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	33.19M	34.68M	26.41M	9.01M	3.54M
Total Assets	95.81M	114.02M	106.48M	90.82M	61.58M
Account Payables	145K	1.26M	3.58M	1.44M	410K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.94M	644K	n/a	n/a	n/a
Other Current Liabilities	4.82M	8.32M	11.61M	4.59M	3.46M
Total Current Liabilities	6.9M	10.22M	15.18M	6.03M	3.87M
Long-Term Debt	18.5M	19.27M	n/a	n/a	n/a
Other Long-Term Liabilities	2.93M	2.61M	94K	115K	29K
Total Long-Term Liabilities	21.44M	21.88M	94K	115K	29K
Total Liabilities	28.33M	32.1M	15.28M	6.14M	3.9M
Total Debt	20.44M	19.91M	n/a	n/a	n/a
Common Stock	4K	4K	3K	3K	2K
Retained Earnings	-244.85M	-223.06M	-161.67M	-111.98M	-81.1M
Comprehensive Income	12K	13K	-11K	-31K	-31K
Shareholders Equity	67.48M	81.92M	91.21M	84.68M	57.68M
Total Investments	48.26M	57.56M	17.63M	47.71M	51.12M